Sensei Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 02/14/2025 | 649,963 | $318,546 | -0.01% | 2.58% |
| VANGUARD GROUP INC | 02/11/2025 | 594,454 | $291,282 | -3.93% | 2.36% |
| 02/14/2025 | 294,374 | $144,273 | 100.00% | 1.17% | |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 172,798 | $84,688 | -0.02% | 0.69% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 156,800 | $76,848 | -27.26% | 0.62% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 148,887 | $72,986 | -8.74% | 0.59% |
| XTX TOPCO LTD | 02/13/2025 | 62,903 | $30,829 | 351.69% | 0.25% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 47,900 | $23,476 | 0.00% | 0.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 38,051 | $18,649 | -57.92% | 0.15% |
| STATE STREET CORP | 02/14/2025 | 25,774 | $12,632 | 0.00% | 0.10% |
| CRESSET ASSET MANAGEMENT, LLC | 02/14/2025 | 19,671 | $9,641 | 0.00% | 0.08% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 14,000 | $6,861 | 100.00% | 0.06% |
| HRT FINANCIAL LP | 02/14/2025 | 11,600 | $5,000 | 100.00% | 0.05% |
| DEUTERIUM CAPITAL MANAGEMENT, LLC | 02/06/2025 | 11,000 | $5,391 | 0.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 5,448 | $2,670 | -22.49% | 0.02% |
| JPMORGAN CHASE & CO | 02/12/2025 | 705 | $345 | -0.28% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 160 | $78 | 100.00% | 0.00% |
| 02/06/2025 | 71 | $35 | 100.00% | 0.00% | |
| UBS GROUP AG | 02/14/2025 | 2 | $1 | 100.00% | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Sensei Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 27 institutional investors and hedge funds held shares of Sensei Biotherapeutics, Inc.. The most heavily invested institutionals were:
Ikarian Capital, LLC: 649,963
VANGUARD GROUP INC: 594,454
BOOTHBAY FUND MANAGEMENT, LLC: 172,798
RENAISSANCE TECHNOLOGIES LLC: 156,800
GEODE CAPITAL MANAGEMENT, LLC: 148,887
XTX Topco Ltd: 62,903
9.34% of Sensei Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.11 M shares in the last 24 months. This purchase volume represents approximately $1.12 M in transactions.